BCR/ABL Regulates Expression of the Cyclin-dependent Kinase Inhibitor p27Kip1 through the Phosphatidylinositol 3-Kinase/AKT Pathway
Open Access
- 1 December 2000
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 275 (50), 39223-39230
- https://doi.org/10.1074/jbc.m007291200
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Differential Regulation of P27Kip1 Expression by Mitogenic and Hypertrophic FactorsThe Journal of cell biology, 2000
- Mutator phenotype of BCR – ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase βOncogene, 1999
- Expression of G1-Phase Cell Cycle Genes during Hematopoietic LineageBiochemical and Biophysical Research Communications, 1997
- Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.The Journal of Experimental Medicine, 1996
- Cyclin D1 provides a link between development and oncogenesis in the retina and breastCell, 1995
- Differential Complementation of Bcr-Abl Point Mutants with c-MycScience, 1994
- Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcomaNature Genetics, 1993
- Dominant negative MYC blocks transformation by ABL oncogenesCell, 1992
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973